BRIEF published on 08/06/2026 at 08:05, 4 days 9 hours ago Pentixapharm publie ses résultats du deuxième trimestre et du premier semestre 2026 et fait progresser son programme de phase 3. Résultats Financiers Procédure Accélérée De La FDA Pentixapharm Pipeline En Oncologie Phase 3 PANDA
BRIEF published on 08/06/2026 at 08:05, 4 days 9 hours ago Pentixapharm Reports Q2 and H1 2026 Results and Advances Phase 3 Program Financial Results Oncology Pipeline FDA Fast Track Pentixapharm Phase 3 PANDA
PRESS RELEASE published on 08/06/2026 at 08:00, 4 days 9 hours ago Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program Pentixapharm Holding AG reports financial results for second quarter and first half of 2026, advancing Phase 3 Panda Program in oncology and cardiovascular sectors Financial Results Oncology Phase 3 Pentixapharm PANDA Program
BRIEF published on 07/31/2026 at 09:05, 10 days 8 hours ago Pentixapharm Holding AG Advances with PentixaFor in Phase 3 Capital Raise Phase 3 PentixaFor Radiopharma PANDA Study
BRIEF published on 07/31/2026 at 09:05, 10 days 8 hours ago Pentixapharm Holding AG fait progresser le PentixaFor en phase 3 Phase 3 Levée De Capitaux PentixaPour Radiopharma Étude PANDA
PRESS RELEASE published on 07/31/2026 at 09:00, 10 days 8 hours ago Original-Research: Pentixapharm Holding AG (von NuWays AG): BUY Research update: Pentixapharm Holding AG positioned for Phase 3 with strong financing secured for PentixaFor diagnostic agent. Potential commercial partnering in 2027. Target price EUR 7.20 Financing Phase 3 Pentixapharm Commercial Partnering Diagnostic Agent
BRIEF published on 07/27/2026 at 20:55, 13 days 20 hours ago Pentixapharm Raises EUR 20.4 Million Through Capital Increase Capital Increase FDA Fast Track Pentixapharm [68Ga]Ga-PentixaFor PANDA Phase 3
BRIEF published on 07/27/2026 at 20:55, 13 days 20 hours ago Pentixapharm lève 20,4 millions d'euros par augmentation de capital Augmentation De Capital Procédure Accélérée De La FDA Pentixapharm [68Ga]Ga-PentixaPour PANDA Phase 3
PRESS RELEASE published on 07/27/2026 at 20:50, 13 days 20 hours ago Pentixapharm Completes Capital Increase – New Shares Placed in Full Pentixapharm completes capital increase, raising EUR 20.4 million for PANDA Phase 3 activities and U.S. expansion after FDA milestones Capital Increase U.S. Expansion Pentixapharm PANDA Phase 3 FDA Milestones
BRIEF published on 07/27/2026 at 20:45, 13 days 20 hours ago Pentixapharm lève 20,4 millions d'euros grâce à une offre sursouscrite Augmentation De Capital Développement Clinique Sursouscription Expansion Américaine Plateforme Théranostique
Published on 08/10/2026 at 15:30, 2 hours 6 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 2 hours 11 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 3 hours 6 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 4 hours 6 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 4 hours 36 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 17:11, 25 minutes ago CORRECTION FROM SOURCE: North Peak Commences 2026 Drilling Campaign at Prospect Mountain, Eureka, Nevada
Published on 08/10/2026 at 16:12, 1 hour 23 minutes ago dK Calls on PANDION AG Bondholders to Join Forces
Published on 08/10/2026 at 15:56, 1 hour 39 minutes ago Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
Published on 08/10/2026 at 15:46, 1 hour 49 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/10/2026 at 15:44, 1 hour 51 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/10/2026 at 11:53, 5 hours 42 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:53, 5 hours 42 minutes ago GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Published on 08/10/2026 at 11:36, 5 hours 59 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 11:36, 5 hours 59 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026
Published on 08/10/2026 at 09:47, 7 hours 48 minutes ago 260810 BENETEAU Transactions sur actions propres
